Dopamine Disruption in the Memory Gate Sparks New Alzheimer's Therapy Route
TL;DR
UC Irvine researchers find dopamine loss in the entorhinal cortex impairs memory in Alzheimer’s models; restoring dopamine with Levodopa (and optogenetics) re-enables memory, signaling a fast-track, dopamine-based therapy path that could supplement protein-clearing strategies.
- Dopamine Depletion: The Hidden Driver of Alzheimer’s Memory Loss Neuroscience News
- Early dopamine disruption in the entorhinal cortex of a knock-in model of Alzheimer’s disease Nature
- Dopamine deficiency found to drive memory impairment in Alzheimer's disease Medical Xpress
- Early Dopamine Loss in Alzheimer’s Entorhinal Cortex Bioengineer.org
Want the full story? Read the original reporting
Read on Neuroscience News